Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (121-130 of 1,123) with videos related to

Pageof 113
Sort By:
World Journal of Urology|January 25, 2005
The role of bisphosphonates in hormone-refractory prostate cancerFred Saad, Pierre Karakiewicz, Paul Perrotte
The Oncologist|November 6, 2010
Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastasesMatti Aapro, Fred Saad, Luis Costa
The Canadian Journal of Urology|February 28, 2007
Isolated solitary bony metastasis of a nonseminomatous germ cell tumorAbdulhadi Aldejmah, Denis Soulières, Fred Saad
The Canadian Journal of Urology|December 4, 2004
The role of bisphosphonates in the management of bone metastases in prostate cancerFred Saad, Kim Chi, Neil Fleshner
Drugs|August 15, 2015
A Practical Approach to the Management of Radiation-Induced Hemorrhagic CystitisXavier Liem, Fred Saad, Guila Delouya
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
The aging male population and medical care for benign prostatic hyperplasia in CanadaNigel S B Rawson, Fred Saad
Urology|September 25, 2017
Author ReplyNeal Shore, Axel Heidenreich, Fred Saad
Current Osteoporosis Reports|December 17, 2010
Androgen deprivation and boneJean-Baptiste Lattouf, Hicham Fadlallah, Fred Saad
European Urology|November 19, 2004
Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of careFred Saad, Carl Olsson, Claude C Schulman
BJU International|January 8, 2010
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonatesFred Saad, Per-Anders Abrahamsson, Kurt Miller
Pageof 113

Showing results (121-130 of 1,123) with videos related to

Sort By:
Pageof 113
World Journal of Urology|January 25, 2005
The role of bisphosphonates in hormone-refractory prostate cancerFred Saad, Pierre Karakiewicz, Paul Perrotte
The Oncologist|November 6, 2010
Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastasesMatti Aapro, Fred Saad, Luis Costa
The Canadian Journal of Urology|February 28, 2007
Isolated solitary bony metastasis of a nonseminomatous germ cell tumorAbdulhadi Aldejmah, Denis Soulières, Fred Saad
The Canadian Journal of Urology|December 4, 2004
The role of bisphosphonates in the management of bone metastases in prostate cancerFred Saad, Kim Chi, Neil Fleshner
Drugs|August 15, 2015
A Practical Approach to the Management of Radiation-Induced Hemorrhagic CystitisXavier Liem, Fred Saad, Guila Delouya
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
The aging male population and medical care for benign prostatic hyperplasia in CanadaNigel S B Rawson, Fred Saad
Urology|September 25, 2017
Author ReplyNeal Shore, Axel Heidenreich, Fred Saad
Current Osteoporosis Reports|December 17, 2010
Androgen deprivation and boneJean-Baptiste Lattouf, Hicham Fadlallah, Fred Saad
European Urology|November 19, 2004
Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of careFred Saad, Carl Olsson, Claude C Schulman
BJU International|January 8, 2010
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonatesFred Saad, Per-Anders Abrahamsson, Kurt Miller
Pageof 113